49 results
Categories
Human Remove Human filter
Veterinary Remove Veterinary filter
Corporate Remove Corporate filter
Type of content
News Remove News filter
Responsible body
PRAC Remove PRAC filter
Patient safety
Yes Remove Yes filter
-
List item
Press release: EMA review of Picato concludes medicine’s risks outweigh its benefits
PRAC, Last updated: 17/04/2020 -
List item
Press release: Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors
PRAC, Last updated: 15/05/2020 -
List item
News: PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids
PRAC, Last updated: 04/09/2020 -
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021 -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022 -
List item
News: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
PRAC, Last updated: 09/07/2021 -
List item
News: COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect
PRAC, Last updated: 22/07/2021 -
List item
News: COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis
PRAC, Last updated: 11/06/2021 -
List item
News: COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
PRAC, Last updated: 14/04/2021 -
List item
News: COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 20/04/2021 -
List item
News: EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
PRAC, Last updated: 09/07/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria
PRAC, Last updated: 10/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update
PRAC, Last updated: 11/03/2021 -
List item
News: Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
PRAC, Last updated: 16/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases
PRAC, Last updated: 25/03/2021 -
List item
News: AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
PRAC, Last updated: 31/03/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 07/04/2021 -
List item
News: Vaxzevria: EMA advises against use in people with history of capillary leak syndrome
PRAC, Last updated: 11/06/2021 -
List item
News: EMA recommends withdrawal of marketing authorisation for amfepramone medicines
PRAC, Last updated: 10/06/2022 -
List item
News: PRAC starts review of topiramate use in pregnancy and women of childbearing potential
PRAC, Last updated: 02/09/2022 -
List item
News: Review of pholcodine medicines started
PRAC, Last updated: 02/09/2022 -
List item
News: New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome
PRAC, Last updated: 30/09/2022 -
List item
News: EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
PRAC, Last updated: 28/10/2022 -
List item
News: EMA recommends withdrawal of pholcodine medicines from EU market
PRAC, Last updated: 02/12/2022